US Patent 11833120 Binding protein drug conjugates comprising anthracycline derivatives

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118331200

Patent Inventor Names

Roger Renzo Beerli0

Ulf Grawunder0

Date of Patent

December 5, 2023

Patent Application Number

171853630

Date Filed

February 25, 2021

Patent Citations

‌

US Patent 10960083 Binding protein drug conjugates comprising anthracycline derivatives

‌

US Patent 10188745 Binding protein drug conjugates comprising anthracycline derivatives

‌

US Patent 10517959 Binding protein drug conjugates comprising anthracycline derivatives

‌

US Patent 8389697 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds

‌

US Patent 8470984 Process for the preparation of morpholinyl anthracycline derivatives

‌

US Patent 8742076 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods

‌

US Patent 8900589 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds

‌

US Patent 9492553 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods

...

Patent Primary Examiner

CPC Code

...

Patent abstract

The present invention relates to an anthracycline (PNU) derivative conjugate comprising a derivative of the anthracycline PNU-159682.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11833120 Binding protein drug conjugates comprising anthracycline derivatives

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11833120 Binding protein drug conjugates comprising anthracycline derivatives